This panel is designed to screen a wide range of inherited conditions linked to early illness in babies and children. It includes categories like metabolic conditions, immunodeficiencies, epilepsy genes, cardiac and connective tissue conditions, hearing loss genes, and other disorders. Importantly, the panel is designed around clinically actionable diagnostic findings. That means results should be meaningful for care decisions.
A positive result means a DNA change was found that is likely to affect health. It may confirm a diagnosis or strongly suggest one. The value is in what you can do next, such as monitoring, treatment, or specialist input. We’ll explain what the finding means, what is known, and what is still uncertain. We’ll also outline practical next steps.